Abstract:Background Amyloid beta (Aβ) which is recognized as a main feature of Alzheimer’s disease (AD) has been proposed to “spread” through anatomically and functionally connected brain regions. The entorhinal cortex and perforant path are the earliest affected brain regions in AD. The perforant path is the most vulnerable circuit in the cortex with respect to both aging and AD. Previous data show that the origins and terminations of the perforant path are susceptible to amyloid deposition at the younger age in AD. Nogo receptor (NgR) plays an essential role in limiting injury-induced axonal growth and experience-dependent plasticity in the adult brain. It has been suggested that NgR is involved in AD pathological features, but the results have been conflicting and the detailed mechanism needs further investigation. In this study, the effect of NgR in the perforant path on the pathological and functional phenotype of APP/PS1 transgenic mice was studied. Methods To genetically manipulate NgR expression, adeno-associated virus (AAV) with short hairpin (shRNA) against NgR was injected into the perforant path of APP/PS1 transgenic mice, followed by an assessment of behavioral, synaptic plasticity and neuropathological phenotypes. NgR was overexpressed or knockdown in neuroblastoma N2a cells and APPswe/HEK293 cells to investigate the interaction between NgR and amyloid precursor protein (APP). Results It is shown that reduction of NgR in the perforant path rescued cognitive and synaptic deficits in APP/PS1 transgenic mice. Concurrently, Aβ production in the perforant path and levels of soluble Aβ and amyloid plaques in the hippocampus were significantly decreased. There was a positive correlation between the total APP protein level and NgR expression both in transgenic mice and in cultured cells, where the α-secretase and β-secretase cleavage products both changed with APP level in parallel. Finally, NgR might inhibit APP degradation through lysosome by Rho/Rho-associated protein kinases (ROCK) signaling pathway. Conclusions Our findings demonstrate that perforant path NgR plays an important role in regulating APP/Aβ level and cognitive functions in AD transgenic mice, which might be related to the suppression of APP degradation by NgR. Our study suggests that NgR in the perforant path could be a potential target for modulating AD progression.

Nogo‐66 promotes β‐amyloid protein secretion via NgR/ROCK‐dependent BACE1 activation

Nogo-66 receptor activation inhibits neurite outgrowth and increases β-amyloid protein secretion of cortical neurons.

Interaction Between Amyloid Precursor Protein and Nogo Receptors Regulates Amyloid Deposition

P3‐446: Effects of Nogo‐66 Receptor on Both Neuronal Neurite Regeneration and Amyloid‐β Protein Production

Effects of Nogo-66 receptor on both neuronal neurite regeneration and amyloid-β protein production

Function of Nogo‐A/Nogo‐A Receptor in Alzheimer's Disease

Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease

Nogo-A Drives Alzheimer's Disease Progression by Inducing Tauopathy Vulnerability.

App Regulates Ngf Receptor Trafficking And Ngf-Mediated Neuronal Differentiation And Survival

A New Chiral Pyrrolyl Alpha-Nitronyl Nitroxide Radical Attenuates Beta-Amyloid Deposition And Rescues Memory Deficits In A Mouse Model Of Alzheimer Disease

SNX15 Regulates Cell Surface Recycling of APP and Aβ Generation

A New Chiral Pyrrolyl α-Nitronyl Nitroxide Radical Attenuates β-Amyloid Deposition and Rescues Memory Deficits in a Mouse Model of Alzheimer Disease

Expressions of Nogo A and its receptor in the cerebrums of patients with Alzheimer disease

C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively

Double-Edged Roles of Nitric Oxide Signaling on APP Processing and Amyloid-β Production In Vitro: Preliminary Evidence from Sodium Nitroprusside

GNG5 is a novel regulator of Aβ42 production in Alzheimer's disease

Correction: Reduction of NgR in Perforant Path Decreases Amyloid-Β Peptide Production and Ameliorates Synaptic and Cognitive Deficits in APP/PS1 Mice

Ginsenoside Re Reduces A Beta Production By Activating Ppar Gamma To Inhibit Bace1 In N2a/App695 Cells

Notoginsenoside R1 ameliorates the inflammation induced by amyloid‑β by suppressing SphK1‑mediated NF‑κB activation in PC12 cells

Involvement of RhoA/ROCK Signaling in Aβ-Induced Chemotaxis, Cytotoxicity and Inflammatory Response of Microglial BV2 Cells

Β-Amyloid Redirects Norepinephrine Signaling to Activate the Pathogenic GSK3β/tau Cascade.